Enterome
By submitting your information in this e-mail message, you agree that such information will be governed by our Privacy Policy related to personal data.
Enterome Press Releases - Enterome Press Releases All 2026 2025 2024 2023 2022 2021 2020 15 June 2026 Enterome presents Phase 1/2 iNHL interim data at EHA demonstrating durable OncoMimics™-induced CD8 T cell responses and clinical activity Read more 28 May 2026 Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma Read more 12 May 2026 Enterome presents Phase 2 indolent non-Hodgkin lymphoma data at EHA showing EO2463 induces B cell target-specific CD8 T-cell expansion correlating with clinical outcomes Read more 29 Jan
saved by
related reading
- Techmemetechmeme.com
- Home - DynaMeddynamed.com
- EHC Q2 2026 Earnings Slidess203.q4cdn.com
- Guidance for Industryfda.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Network Bio Q1 2023 Investor Update - by network.bionetworkbio.substack.com
- News — Pacific 8 Venturespac8.com
- Treeline | Blogtreeline.bio
- Current and Emerging Approaches for Spine Tumor Treatmentpmc.ncbi.nlm.nih.gov
- Faecal transplants can treat some cancers — but probably won’t ever be widely usednature.com
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org